Bruce & Co 13F annual report

Bruce & Co is an investment fund managing more than $299 billion ran by R. Bruce. There are currently 38 companies in Bruce’s portfolio. The largest investments include Uhaul B and Merck, together worth $60.4 billion.

Limited to 30 biggest holdings

$299 billion Assets Under Management (AUM)

As of 2nd August 2024, Bruce & Co’s top holding is 542,950 shares of Uhaul B currently worth over $32.6 billion and making up 10.9% of the portfolio value. In addition, the fund holds 224,500 shares of Merck worth $27.8 billion. The third-largest holding is Abbvie Inc worth $27.7 billion and the next is NextEra Inc worth $23.6 billion, with 333,300 shares owned.

Currently, Bruce & Co's portfolio is worth at least $299 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Bruce & Co

The Bruce & Co office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, R. Bruce serves as the Vice President at Bruce & Co.

Recent trades

In the most recent 13F filing, Bruce & Co revealed that it had opened a new position in Bunge and bought 50,000 shares worth $5.34 billion.

The investment fund also strengthened its position in Uhaul B by buying 6,600 additional shares. This makes their stake in Uhaul B total 542,950 shares worth $32.6 billion.

On the other hand, R. Bruce disclosed a decreased stake in Xel Energy by 0.3%. This leaves the value of the investment at $10.5 billion and 196,000 shares.

One of the smaller hedge funds

The two most similar investment funds to Bruce & Co are O'keefe Stevens Advisory and Atlantic Edge Private Wealth Management. They manage $299 billion and $299 billion respectively.


R. Bruce investment strategy

Bruce & Co’s portfolio is diversified across 8 sectors. Currently, their heaviest sector is Utilities — making up 23.5% of the total portfolio value. The fund focuses on investments in the United States as 44.7% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 21% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $171 billion.

The complete list of Bruce & Co trades based on 13F SEC filings

These positions were updated on August 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Uhaul B
1.23%
542,950
$32,587,859,000 10.89%
Merck
1.72%
224,500
$27,793,100,000 9.29%
Abbvie Inc
17.03%
161,500
$27,700,480,000 9.26%
NextEra Energy Inc
13.52%
333,300
$23,600,973,000 7.89%
Allstate
2.59%
130,500
$20,835,630,000 6.96%
Duke Energy Corp.
0.94%
205,816
$20,628,938,000 6.89%
CMS Energy Corporation
1.27%
320,000
$19,049,600,000 6.37%
At & T
2.39%
984,000
$18,804,240,000 6.29%
Abbott
1.53%
152,300
$15,825,493,000 5.29%
Insteel
No change
343,423
$10,632,376,000 3.55%
Xel Energy
33.11%
196,000
$10,468,360,000 3.50%
Apple Inc
13.11%
39,700
$8,361,614,000 2.79%
Pfizer Inc.
2.94%
276,400
$7,733,672,000 2.58%
Avista Corp.
No change
201,500
$6,973,915,000 2.33%
Darling Ingredients Inc
7.14%
150,000
$5,512,500,000 1.84%
Bunge
Opened
50,000
$5,338,500,000 1.78%
Uhaul
6.07%
75,105
$4,636,232,000 1.55%
Newmont Corp
52.44%
100,000
$4,187,000,000 1.40%
Bausch Health
14.60%
550,000
$3,833,500,000 1.28%
RLI Corp.
1,020.00%
22,400
$3,151,456,000 1.05%
Archer Daniels
Opened
50,000
$3,022,500,000 1.01%
Edap
No change
553,652
$3,011,867,000 1.01%
Vicor Corp.
133.33%
70,000
$2,321,200,000 0.78%
Supernus
No change
82,105
$2,196,309,000 0.73%
Xm Sirius
No change
557,843
$1,578,696,000 0.53%
Ashland Inc
No change
15,000
$1,417,350,000 0.47%
Lava Theraputics
No change
771,874
$1,389,373,000 0.46%
Mannkind Corp
No change
195,073
$1,018,281,000 0.34%
Kodiak Sciences Inc
10.57%
423,000
$994,050,000 0.33%
Fate Theraputics
109.79%
300,000
$984,000,000 0.33%
Igm Bioscience
53.85%
100,000
$687,000,000 0.23%
Organon
0.58%
31,370
$649,359,000 0.22%
Viatris Inc.
1.00%
58,833
$625,395,000 0.21%
Caribou Biosciences
50.00%
300,000
$492,000,000 0.16%
Wec Energy
Opened
4,509
$353,776,000 0.12%
908 Devices Inc.
No change
68,286
$351,673,000 0.12%
Personalis Inc
No change
300,000
$351,000,000 0.12%
Warner Bros. Discovery
11.36%
11,851
$88,171,000 0.03%
No transactions found
Showing first 500 out of 38 holdings